These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19700653)

  • 1. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of fecal DNA methylation biomarkers detection in gastric cancer screening].
    Guo P; Zhou XJ; Xu L; Chen H; Zhao L; Sun MH; Hu H
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):808-812. PubMed ID: 33765723
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
    Wang DR; Tang D
    World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
    Oncologist; 2017 Oct; 22(10):1178-1188. PubMed ID: 28754720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
    Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
    World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
    Huang ZH; Li LH; Yang F; Wang JF
    World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
    Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
    Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
    Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
    Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of combined detection of ITGA4 and SFRP2 gene methylation in stool DNA in diagnosis and prognostic evaluation of colorectal tumors].
    Jin H; Pang L; Li H; Xu M; Yan H; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):891-897. PubMed ID: 34238742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT promoter methylation and field defect in sporadic colorectal cancer.
    Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
    J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
    Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
    Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.